Insights

Clinical Trials Readiness Teiko specializes in immune measurement for clinical trials using high-dimensional cytometry and operates a CLIA registered lab, signaling a strong fit for sponsors conducting immunotherapy and immune monitoring programs seeking validated, scalable analytics.

AI Enhanced Insights Recent product launches such as Pocket Immunologist and AI-powered dashboard enhancements indicate a focus on accelerating data interpretation, offering sales opportunities to research teams needing faster decision support and interpretable cytometry results.

Strategic Partnerships Collaboration with Massachusetts General Hospital on CD38 positive T cell signatures demonstrates credibility and a pathway to co development or sponsored studies, suggesting opportunities to expand with top tier academic centers and their networks.

Expansion in Data Accessibility New features like Download All and upgraded samples overview dashboards position Teiko as a data productivity vendor, appealing to trial sponsors and CROs that require streamlined data retrieval, reproducibility, and enhanced visualization in dashboards.

Growth and Momentum Sustained product releases and active marketing activity alongside a growing revenue stream place Teiko as a rising provider in the immune measurement space, presenting cross sell and upsell opportunities to mid to large biotech and pharma clients pursuing immunotherapy programs.

Similar companies to Teiko

Teiko Tech Stack

Teiko uses 8 technology products and services including Google Ads, LinkedIn Ads, Looker, and more. Explore Teiko's tech stack below.

Media & News

Teiko's Email Address Formats

Teiko uses at least 1 email format:
Teiko Email FormatsExamplePercentage
First@teiko.bioJohn@teiko.bio
100%

Frequently Asked Questions

What is Teiko's stock symbol?

Minus sign iconPlus sign icon
Teiko is a publicly traded company; the company's stock symbol is 3302.T.

What is Teiko's official website and social media links?

Minus sign iconPlus sign icon
Teiko's official website is teiko-labs.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Teiko generate?

Minus sign iconPlus sign icon
As of August 2026, Teiko's annual revenue is estimated to be $10M - $25M.

What is Teiko's NAICS code?

Minus sign iconPlus sign icon
Teiko's NAICS code is 6215 - Medical and Diagnostic Laboratories.

How many employees does Teiko have currently?

Minus sign iconPlus sign icon
As of August 2026, Teiko has approximately 24 employees across 2 continents, including North America and Asia. Key team members include Associate Director, Clinical Development: J. S. Explore Teiko's employee directory with LeadIQ.

What industry does Teiko belong to?

Minus sign iconPlus sign icon
Teiko operates in the Medical and Diagnostic Laboratories industry.

What technology does Teiko use?

Minus sign iconPlus sign icon
Teiko's tech stack includes Google Ads, LinkedIn Ads, Looker, Amazon Web Services, Docker, WordPress, Microsoft Azure and DigitalOcean Web Hosting.

What is Teiko's email format?

Minus sign iconPlus sign icon
Teiko's email format typically follows the pattern of First@teiko.bio. Find more Teiko email formats with LeadIQ.

How much funding has Teiko raised to date?

Minus sign iconPlus sign icon
As of August 2026, Teiko has raised $12M in funding. The last funding round occurred on Jan 01, 2025.
Teiko logo

Teiko

Medical and Diagnostic LaboratoriesUtah, United States11-50 Employees

Teiko is a Salt Lake City-based medical and diagnostic laboratory that provides immune-state assessment for clinical trials and patients. It operates a CLIA-registered facility and uses high-dimensional cytometry to profile the immune systems of trial participants. The company focuses on delivering objective immune data to support immunotherapy research and patient care.

Its customers include pharmaceutical developers and clinical researchers conducting immunotherapy trials who need precise immune profiling to interpret responses and resistance. In 2025, Teiko introduced Pocket Immunologist, an AI-powered feature within its dashboards to aid interpretation of complex cytometry data. It has also collaborated with Massachusetts General Hospital on a study examining CD38+ T cell exhaustion and resistance to immune checkpoint blockade.

Section iconCompany Overview

Stock Symbol
3302.T
NAICS Code
6215 - Medical and Diagnostic Laboratories
Employees
11-50

Section iconFunding & Financials

  • $12M

    Teiko has raised a total of $12M of funding over 4 rounds. Their latest funding round was raised on Jan 01, 2025 as a Venture Round.

  • $10M - $25M

    Teiko's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.